key: cord-0802967-h4awz30s
authors: Sutton, Desmond; Fuchs, Karin; D’Alton, Mary; Goffman, Dena
title: Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
date: 2020-04-13
journal: N Engl J Med
DOI: 10.1056/nejmc2009316
sha: d03b305cda4fc7bc0206cd46e6dac5705ce6429c
doc_id: 802967
cord_uid: h4awz30s

nan

for SARS-CoV-2 on admission became symptomatic postpartum; repeat SARS-CoV-2 testing 3 days after the initial test was positive.

Our use of universal SARS-CoV-2 testing in all pregnant patients presenting for delivery revealed that at this point in the pandemic in New York City, most of the patients who were positive for SARS-CoV-2 at delivery were asymptomatic, and more than one of eight asymptomatic patients who were admitted to the labor and delivery unit were positive for SARS-CoV-2. Although this prevalence has limited generalizability to geographic regions with lower rates of infection, it underscores the risk of Covid-19 among asymptomatic obstetrical patients. Moreover, the true prevalence of infection may be underreported because of false negative results of tests to detect SARS-CoV-2. 3 The potential benefits of a universal testing approach include the ability to use Covid-19 status to determine hospital isolation practices and 

COVID-19 in pregnancy: early lessons

COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Correspondence Copyright © 2020 Massachusetts Medical Society

Columbia University Irving Medical Center New York, NY dg2018@ cumc . columbia . edu Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.This letter was published on April 13, 2020, at NEJM.org.